Building antimicrobial viruses from breast milk

January 15, 2016, National Physical Laboratory
Building antimicrobial viruses from breast milk
Credit: iStock.com/imagestock

Scientists from the National Physical Laboratory (NPL) and UCL have converted a breast milk protein into an artificial virus that kills bacteria on contact.

As well as providing all the energy and nutrients that infants need for the first months of life, breast milk protects against infectious diseases. Lactoferrin is a protein in milk which provides antimicrobial protection to infants, effectively killing bacteria, fungi and even viruses.

The antimicrobial activities of this protein are mainly due to a tiny fragment, less than a nanometre across, made up of six amino acids. Based on the metrology of antimicrobial mechanisms, the team predicted that copies of this fragment gather at the same time, and at the same point, to attack bacterial cells by targeting and disrupting microbial membranes.

Recognising the potential applications in the fight against antimicrobial resistance, the team re-engineered the fragment into a nanoscale building block which self-assembles into virus-like capsules, to effectively target bacteria (see figure below). Not only can these capsules recognise and bind to bacteria, but they also rapidly convert into membrane-damaging holes at precise landing positions.

Building antimicrobial viruses from breast milk
The chemical structure of the nanoscale building block (left) and its assembly into a virus-like capsule (right, topographic AFM image)

Hasan Alkassem, a joint NPL/UCL EngD student who worked on the project, explains:

"To monitor the activity of the capsules in real time we developed a high-speed measurement platform using . The challenge was not just to see the capsules, but to follow their attack on bacterial membranes. The result was striking: the capsules acted as projectiles porating the membranes with bullet speed and efficiency."

Remarkably, however, these capsules do not affect surrounding human cells. Instead, they infected them like viruses do. When viruses are inside human cells they release their genes, which then use the body's cellular machinery to multiply and produce more viruses. But if viral genes are replaced with drugs or therapeutic genes, viruses become effective tools in the pursuit of gene therapy to cure many diseases, from cancer to .

The research team explored this possibility and inserted model genes into the capsules. These genes were designed to switch off, or silence, a target process in . The capsules harmlessly delivered the genes into the cells and effectively promoted the desired silencing. With therapeutic genes, this capability could be used to treat disorders resulting from a single mutated gene. Sickle-cell disease, cystic fibrosis or Duchenne muscular dystrophy are incurable at present, but can be cured by correcting corresponding mutated . The therefore can serve as delivery vehicles for cures.

The findings are reported in Chemical Science - a journal of the Royal Society of Chemistry which publishes findings of exceptional significance from across the chemical sciences - and effectively demonstrate how measurement science can offer innovative solutions to healthcare, which build on and extend natural disease-fighting capabilities.

Explore further: Scientists copy the ways viruses deliver genes

More information: Valeria Castelletto et al. Structurally plastic peptide capsules for synthetic antimicrobial viruses, Chem. Sci. (2016). DOI: 10.1039/C5SC03260A

Related Stories

Scientists copy the ways viruses deliver genes

August 11, 2011

Scientists at the National Physical Laboratory (NPL) have mimicked the ways viruses infect human cells and deliver their genetic material. The research hopes to apply the approach to gene therapy – a therapeutic strategy ...

Recommended for you

New battery gobbles up carbon dioxide

September 21, 2018

A new type of battery developed by researchers at MIT could be made partly from carbon dioxide captured from power plants. Rather than attempting to convert carbon dioxide to specialized chemicals using metal catalysts, which ...

Scientists solve the golden puzzle of calaverite

September 21, 2018

Scientists from Russia and Germany have shed light on the crystalline structure of calaverite, foretelling the existence of a new gold compound previously unknown to chemists. The results of their study were published in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.